Phosphoantigen-induced Conformational Change of Butyrophilin 3A1 (BTN3A1) and Its Implication on Vγ9Vδ2 T Cell Activation
Overview
Authors
Affiliations
Human Vγ9Vδ2 T cells respond to microbial infections as well as certain types of tumors. The key initiators of Vγ9Vδ2 activation are small, pyrophosphate-containing molecules called phosphoantigens (pAgs) that are present in infected cells or accumulate intracellularly in certain tumor cells. Recent studies demonstrate that initiation of the Vγ9Vδ2 T cell response begins with sensing of pAg via the intracellular domain of the butyrophilin 3A1 (BTN3A1) molecule. However, it is unknown how downstream events can ultimately lead to T cell activation. Here, using NMR spectrometry and molecular dynamics (MD) simulations, we characterize a global conformational change in the B30.2 intracellular domain of BTN3A1 induced by pAg binding. We also reveal by crystallography two distinct dimer interfaces in the BTN3A1 full-length intracellular domain, which are stable in MD simulations. These interfaces lie in close proximity to the pAg-binding pocket and contain clusters of residues that experience major changes of chemical environment upon pAg binding. This suggests that pAg binding disrupts a preexisting conformation of the BTN3A1 intracellular domain. Using a combination of biochemical, structural, and cellular approaches we demonstrate that the extracellular domains of BTN3A1 adopt a V-shaped conformation at rest, and that locking them in this resting conformation without perturbing their membrane reorganization properties diminishes pAg-induced T cell activation. Based on these results, we propose a model in which a conformational change in BTN3A1 is a key event of pAg sensing that ultimately leads to T cell activation.
Liu J, Wu M, Yang Y, Mei X, Wang L, Wang J Cell Commun Signal. 2024; 22(1):459.
PMID: 39342337 PMC: 11439235. DOI: 10.1186/s12964-024-01834-0.
The Evolving Portrait of γδ TCR Recognition Determinants.
Sok C, Rossjohn J, Gully B J Immunol. 2024; 213(5):543-552.
PMID: 39159405 PMC: 11335310. DOI: 10.4049/jimmunol.2400114.
Singh R, Rani S, Jin Y, Hsiao C, Wiemer A Eur J Med Chem. 2024; 276:116673.
PMID: 39029338 PMC: 11323222. DOI: 10.1016/j.ejmech.2024.116673.
Vγ9Vδ2 T cells recognize butyrophilin 2A1 and 3A1 heteromers.
Fulford T, Soliman C, Castle R, Rigau M, Ruan Z, Dolezal O Nat Immunol. 2024; 25(8):1355-1366.
PMID: 39014161 DOI: 10.1038/s41590-024-01892-z.
The B7:CD28 family and friends: Unraveling coinhibitory interactions.
Burke K, Chaudhri A, Freeman G, Sharpe A Immunity. 2024; 57(2):223-244.
PMID: 38354702 PMC: 10889489. DOI: 10.1016/j.immuni.2024.01.013.